Search
Now showing items 1-3 of 3
Predictores de remisión clínica en pacientes con artritis reumatoide temprana : revisión sistemática
(Universidad del RosarioMaestría en EpidemiologíaFacultad de medicina, 2018)
Background/purpose: Clinical remission is the target in patients with rheumatoid arthritis (RA). Early diagnosis, optimal treatment, and recognize of baseline characteristics represents a crucial step for controlling the ...
Análisis costo versus efectividad del Etanercept, Infliximab y Adalimumab, en pacientes con artritis reumatoide refractaria
(Universidad del RosarioMaestría en Administración en SaludFacultad de administración, 2017)
Currently there are several technologies to treat rheumatoid arthritis (RA), which has become an industry since the treatments for it can be for long periods of time, with significant costs for the Colombian health system. ...
Eficacia y seguridad del biosimilar ABP 501 (Adalimumab) comparado con biosimilar CT-P13 (Infliximab) en pacientes adultos con artritis reumatoide. Revisión sistemática
Introduction: There is no scientific evidence of comparative studies between biosimilars that demonstrate safety and efficacy, this being relevant for clinicians and insurers to feel supported at the time of acquiring and ...